PULSE BIOSCIENCES, INC. (PLSE)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PULSE BIOSCIENCES, INC. reported revenue of $350.0K. The company ran a net loss, with a net margin of -20794.6%. It held $94.54M in total assets against $13.88M in total liabilities.
Key ratios (FY2025)
-21982.6%
Operating margin
-20794.6%
Net margin
-90.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $350.0K | $0 | $0 | $700.0K | $1.42M | $0 | — | — | — | — |
| Cost of Revenue | $539.0K | $0 | $0 | $11.94M | $1.97M | $0 | — | — | — | — |
| Operating Income | -$76.94M | -$56.26M | -$43.57M | -$58.06M | -$63.01M | -$49.97M | -$47.95M | -$37.55M | -$25.57M | -$9.52M |
| Net Income | -$72.78M | -$53.59M | -$42.21M | -$58.51M | -$63.66M | -$49.85M | -$46.97M | -$37.55M | -$25.57M | -$9.52M |
| EPS (Diluted) | $-1.08 | $-0.92 | $-0.85 | $-1.72 | $-2.28 | $-2.14 | — | — | — | — |
| Total Assets | $94.54M | $132.46M | $59.15M | $77.88M | $54.25M | $41.29M | $41.91M | $70.64M | $49.82M | $26.31M |
| Total Liabilities | $13.88M | $17.60M | $14.79M | $80.12M | $18.56M | $18.40M | $11.18M | $4.31M | $3.83M | $1.02M |
| Shareholders' Equity | $80.66M | $114.86M | $44.36M | -$2.25M | $35.69M | $22.89M | $30.74M | $66.33M | $45.99M | $25.30M |
| Cash & Equivalents | $80.73M | $118.04M | $44.37M | $61.14M | $28.61M | $12.46M | $6.90M | $51.10M | $3.39M | $2.09M |
| Operating Cash Flow | -$54.12M | -$36.34M | -$33.04M | -$47.01M | -$54.10M | -$35.37M | -$34.19M | -$23.90M | -$11.09M | -$8.05M |
| Capital Expenditures | $315.0K | $125.0K | $121.0K | $401.0K | $437.0K | $441.0K | $608.0K | $276.0K | $2.55M | $64.0K |
| Shares Outstanding | 67.84M | 65.93M | 55.14M | 37.23M | 29.72M | 25.55M | 20.82M | 20.59M | 16.82M | 13.31M |